The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Atherosclerosis

• Publication date

  2000-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0021-9150(00)00381-6PMID 11058707
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation.

  1998cited by this paper
• Peroxisome proliferator-activated receptors, orphans with ligands and functions.

  1997cited by this paper
• Dietary fish oil. Influence on lesion regression in the porcine model of atherosclerosis.

  1997cited by this paper
• Precipitation methods for high-density lipoprotein cholesterol measurement compared, and final evaluation under routine operating conditions of a method with a low sample-to-reagent ratio.

  1997cited by this paper
• n-3 fatty acids and serum lipoproteins: animal studies.

  1997cited by this paper
• n-3 fatty acids and serum lipoproteins: human studies.

  1997cited by this paper
• Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants.

  1997cited by this paper
• Polyunsaturated fatty acids and platelet aggregation.

  1996cited by this paper
• Antiarrhythmic effects of polyunsaturated fatty acids. Recent studies.

  1996cited by this paper
• Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR.

  1996cited by this paper
• Dietary fish oil and blood lipids.

  1996cited by this paper
• Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression.

  1996cited by this paper
• Effects of fish oil on oxidation resistance of VLDL in hypertriglyceridemic patients.

  1996cited by this paper
• Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia.

  1996cited by this paper
• Polyunsaturated fatty acids and function of platelets and endothelial cells.

  1996cited by this paper
• Dietary polyunsaturates and peroxidation of low density lipoprotein.

  1996cited by this paper
• Fish consumption, fish oil, lipids, and coronary heart disease.

  1996cited by this paper
• Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.

  1995influential reference
• Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages.

  1995cited by this paper
• Effects of linoleate-enriched and oleate-enriched diets in combination with alpha-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans.

  1994cited by this paper
• Metabolism of VLDL and LDL subclasses.

  1994cited by this paper
• Effect of n−3 fatty acid-rich fish oil supplementation on the oxidation of low density lipoproteins

  1994cited by this paper
• n-3 fatty acid incorporation into LDL particles renders them more susceptible to oxidation in vitro but not necessarily more atherogenic in vivo.

  1994cited by this paper
• Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects.

  1993cited by this paper
• Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment.

  1993influential reference
• Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia.

  1993cited by this paper
• Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients.

  1993cited by this paper
• Modification of lipid-related atherosclerosis risk factors by ω3 fatty acid ethyl esters in hypertriglyceridemic patients

  1993cited by this paper
• Mechanism of action of fibrates.

  1993cited by this paper
• Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies.

  1992cited by this paper
• Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein.

  1992cited by this paper
• Both inherited susceptibility and environmental exposure determine the low-density lipoprotein-subfraction pattern distribution in healthy Dutch families.

  1992cited by this paper
• Low density lipoprotein particle size and coronary artery disease.

  1992cited by this paper
• Effect of dietary supplementation with n-3 polyunsaturated fatty acids on physical properties and metabolism of low density lipoprotein in humans.

  1992cited by this paper
• Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.

  1991influential reference
• Improved fluorometric determination of malonaldehyde.

  1991cited by this paper
• Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins.

  1991cited by this paper
• Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis.

  1990cited by this paper
• Continuous monitoring of in vitro oxidation of human low density lipoprotein.

  1989cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals.

  1989cited by this paper
• Cardiovascular effects of n-3 fatty acids.

  1988cited by this paper
• Effects of Dietary Fish Oil and Omega-3 Fatty Acids on Platelets and Blood Vessels

  1988cited by this paper
• Cardiovascular effects of N-3 fatty acids.

  1988cited by this paper
• Low-density lipoprotein subclass patterns and risk of myocardial infarction.

  1988cited by this paper
• Abnormal regulation of LDL receptor activity and abnormal cellular metabolism of hypertriglyceridaemic low density lipoprotein: normalization with bezafibrate therapy

  1987cited by this paper
• Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions.

  1987cited by this paper
• Fibric acids: effects on lipids and lipoprotein metabolism.

  1987cited by this paper
• The triglyceride issue: a view from Framingham.

  1986cited by this paper
• Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts. Normalization with bezafibrate therapy.

  1985cited by this paper
• Plasma triglyceride determines structure-composition in low and high density lipoproteins.

  1984cited by this paper
• Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.

  1984cited by this paper
• Improved direct determination of alpha- and gamma-tocopherols in plasma and platelets by liquid chromatography, with fluorescence detection.

  1982cited by this paper
• Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies.

  1979cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Effect of Novel Stratified Lipid Risk by "LDL-Window" and Flow-Mediated Dilation on the Prognosis of Coronary Artery Disease Using the FMD-J Study A Data.

  2022cites this paper
• Incidental finding of lipaemia retinalis on diabetic retinal screening

  2021cites this paper
• Long-Term Comparison of Ethyl Icosapentate vs. Omega-3-Acid Ethyl in Patients With Cardiovascular Disease and Hypertriglyceridemia (DEFAT Trial).

  2019cites this paper
• Changes in Lipid Profiles among Patients with with Coronary Vascular Diseases Treated with Omega3 and Vitamin E: A Randomized Control Clinical Trial

  2018cites this paper
• The Acute Effects of Cigarette Smoking on the Functional State of High Density Lipoprotein

  2018cites this paper
• Clinical implications of eicosapentaenoic acid/arachidonic acid ratio (EPA/AA) in adult patients with congenital heart disease

  2017cites this paper
• Comparative evaluation of the effects of ezetimibe and atorvastatin on serum lipid profile changes in experimental hypercholesterolemia in cat

  2017cites this paper
• Omega-3 Free Fatty Acids for the Maintenance of Remission in Crohn Disease

  2017cites this paper
• Comparative evaluation between Chitosan and Salvadora persica on serum lipid profile changes in hyperlipidemic rabbits

  2017cites this paper
• Comparative evaluation between chitosan and atorvastatin on serum lipid profile changes in hyperlipidemic cats.

  2016cites this paper
• Omega-3 Polyunsaturated Fatty Acids and Hyperlipidaemias

  2016cites this paper
• Switching statin-treated patients from fenofibrate to the prescription omega-3 therapy icosapent ethyl: a retrospective case series

  2016cites this paper
• Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia.

  2015cites this paper
• ÔMEGA-3 E REDUÇÃO DOS TRIGLICERÍDEOS NO PACIENTE COM DOENÇA CARDIOVASCULAR OMEGA-3 AND THE REDUCTION OF TRIGLYCERIDES IN THE PATIENT WITH CARDIOVASCULAR DISEASE

  2015cites this paper
• N -3 Fatty Acids: Role in Treating Dyslipidemias and Preventing Cardiovascular Disease

  2015cites this paper
• α-Lipoic acid as a triglyceride-lowering nutraceutical.

  2015cites this paper
• Over-the-counter fish oil use in a county hospital: Medication use evaluation and efficacy analysis.

  2015cites this paper
• Efeito do pré-tratamento com óleo de peixe sobre o infarto agudo do miocárdio em ratos.

  2014cites this paper
• Omacor and Omega-3 Fatty Acids for Treatment of Coronary Artery Disease and the Pleiotropic Effects

  2014cites this paper
• Recommendations for severe hypertriglyceridemia treatment, are there new strategies?

  2014cites this paper
• Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.

  2014cites this paper
• Health Care Guideline Lipid Management in Adults

  2013cites this paper
• Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults.

  2013cites this paper
• Uso terapéutico de ácidos grasos omega-3 de prescripción en pacientes con hipertrigliceridemia grave

  2013cites this paper
• n-3 PUFAs and heart failure.

  2013cites this paper
• Omega-3 polyunsaturated fatty acids for major depressive disorder

  2013cites this paper
• Small dense LDL: risk factor for coronary artery disease (CAD) and its therapeutic modulation.

  2012cites this paper
• Fish oil supplementation & coronary artery disease: does it help?

  2012cites this paper
• Comparison of the effects of n-3 long chain polyunsaturated fatty acids and fenofibrate on markers of inflammation and vascular function, and on the serum lipoprotein profile in overweight and obese subjects.

  2012cites this paper
• Investigations into hyperlipidemia and its possible associations with pancreatitis in dogs

  2012cites this paper
• Fish as a dietary source of healthy long chain n-3 polyunsaturated fatty acids (LCn-3 PUFA) and vitamin D: A Review of the current literature

  2012cites this paper
• Gemfibrozilo versus aceite de Sacha Inchi en la reducción de niveles de triglicéridos séricos en Rattus rattus var albinus

  2012cites this paper
• Targeting PPARs in metabolic risk management: A pharmacological and nutritional approach

  2011cites this paper
• Effects of similar intakes of marine n-3 fatty acids from enriched food products and fish oil on cardiovascular risk markers in healthy human subjects

  2011cites this paper
• "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.

  2011cites this paper
• Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: Results from a six month randomized controlled trial.

  2011cites this paper
• Evaluation of negative and positive health effects of n-3 fatty acids as constituents of food supplements and fortified Foods. Opinion of the Steering Committee of the Norwegian Scientific Committee for Food Safety

  2011influential citation
• Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients

  2010cites this paper
• Lipid metabolism and hyperlipidemia in dogs.

  2010cites this paper
• Effects of dietary fish oil on thyroid hormone signaling in the liver.

  2010cites this paper
• Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease

  2010cites this paper
• Wat zijn de oorzaken van hypertriglyceridemie? Moet een hypertriglyceridemie worden behandeld en zo ja, met welk medicament?

  2010cites this paper
• Fish Oil for the Treatment of Cardiovascular Disease

  2010cites this paper
• Ácidos grasos omega-3 y prevención cardiovascular

  2010cites this paper
• Effect of non-statin lipid lowering and anti-obesity drugs on LDL subfractions in patients with mixed dyslipidaemia.

  2010cites this paper
• Long‐chain n‐3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease

  2009cites this paper
• Dyslipidemia and cardiovascular risk: the importance of early prevention.

  2009cites this paper
• Maintaining Cardiovascular Health in Patients With Mixed Dyslipidemia Optimizing the Management of Hypertriglyceridemia and Non-HDL Cholesterol

  2009cites this paper
• Choline and Its Products Acetylcholine and Phosphatidylcholine

  2009cites this paper
• Omega-3 Ethylester Concentrate

  2009cites this paper
• Fish Oil and Fenofibrate for the Treatment of Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy:

  2009cites this paper
• Fish Oil and Fenofibrate for the Treatment of Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy: Results of ACTG A5186

  2008cites this paper
• Hypertriglyceridemia and hypercholesterolemia: effects of drug treatment on fatty acid composition of plasma lipids and membranes.

  2008cites this paper
• Omega-3-acid Ethyl Esters (Lovaza) For Severe Hypertriglyceridemia

  2008cites this paper
• Role of lipoprotein lipase in triglyceride metabolism: potential therapeutic target

  2008cites this paper
• Table 1 Pivotal Studies of Omega-3-Acid Ethyl Esters ( Lovaza )

  2008cites this paper
• Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications

  2008cites this paper
• Fish oil in the treatment of dyslipidemia

  2008cites this paper
• Peroxisome proliferator-activated receptors and the metabolic syndrome

  2008cites this paper
• Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials.

  2008cites this paper
• Chylomicronemia and the chylomicronemia syndrome: a practical approach to management.

  2008cites this paper
• [Omega-3 polyunsaturated fatty acids in the prevention of atherosclerosis].

  2008cites this paper
• Supplementation with Eskimo® Skin Care improves skin elasticity in women. A pilot study

  2008cites this paper
• Therapeutic Class Review Lipotropics - Niacin and Omega-3 Acid Ethyl Esters

  2008cites this paper
• Omega 3 Fatty Acids in the Treatment of Dyslipidemia

  2008cites this paper
• Investigations into idiopathic hypertriglyceridemia in the Miniature Schnauzer in North America

  2008cites this paper
• Azomega-3többszörösentelítetlenzsírsavak azatherosclerosismegelôzésében

  2008cites this paper
• CONSUMO DE PESCADO, OMEGA- 3 Y FACTORES DE RIESGO CARDIOVASCULAR

  2007cites this paper
• High plasma level of remnant-like particles cholesterol in familial combined hyperlipidemia.

  2007cites this paper
• Enriched n-3 polyunsaturated fatty acids of dense LDL subfraction in Japanese women with small, dense LDL categorized by non-denaturing gradient gel electrophoresis

  2007cites this paper
• Food matrices affect the bioavailability of (n-3) polyunsaturated fatty acids in a single meal study in humans

  2007cites this paper
• 3.2 Choline and Its Products Acetylcholine and Phosphatidylcholine Choline

  2007cites this paper
• Omega-3 fatty acid ethyl esters (Omacor ® ) for the treatment of hypertriglyceridemia

  2007cites this paper
• Role of Prescription Omega‐3 Fatty Acids in the Treatment of Hypertriglyceridemia

  2007cites this paper
• Lipoprotein metabolism in chronic renal insufficiency

  2007cites this paper
• Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.

  2007cites this paper
• Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids.

  2006cites this paper
• Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally.

  2006cites this paper
• The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters.

  2006cites this paper
• The Triglyceride-Lowering Effects of a Modest Dose of Docosahexaenoic Acid Alone Versus in Combination with Low Dose Eicosapentaenoic Acid in Patients with Coronary Artery Disease and Elevated Triglycerides

  2006cites this paper
• An Evidence-Based Approach to the Use of Combination Drug Therapy for Mixed Dyslipidemia

  2006cites this paper
• N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination.

  2006cites this paper
• A Review of Omega-3 Ethyl Esters for Cardiovascular Prevention and Treatment of Increased Blood Triglyceride Levels

  2006influential citation
• The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters

  2006cites this paper
• The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia

  2006cites this paper
• Effects of pioglitazone in familial combined hyperlipidaemia

  2006cites this paper
• The Changing Face of Dyslipidemia Therapies

  2006cites this paper
• Th-P15:240 The effect of ageing and obesity on the expression of dyslipidemia in children from FCH families

  2006cites this paper
• A Review of Omega-3 Ethyl Esters for Cardiovascular Prevention and Treatment of Increased Blood Triglyceride Levels

  2006cites this paper
• Lipoprotein lipase S447X : from benefical gene variant to gene therapy

  2006cites this paper
• Molecular mechanisms involved in the regulation of lipid and lipoprotein metabolism by fish oil

  2006cites this paper
• Targeting PPARs in metabolic risk management: A pharmacological and nutritional approach

  2006cites this paper
• Lipoprotein Lipase S447X: A Naturally Occurring Gain-of-Function Mutation

  2006cites this paper
• Farmacología de los ácidos grasos omega-3

  2006cites this paper
• n-3 fatty acids and cardiovascular disease.

  2006cites this paper
• Tratamiento de la hipertrigliceridemia: fibratos frente a ácidos grasos omega-3

  2006cites this paper
• Beneficial effects of omega-3 fatty acids: the current evidence.

  2006influential citation
• Role of Insulin Resistance in Familial Combined Hyperlipidemia

  2005cites this paper
• Changes in antibiotic use in Dutch hospitals over a six-year period: 1997 to 2002.

  2005cites this paper
• Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia

  2005cites this paper